Erschienen in:
30.08.2019 | Commentary
Overuse of intravenous infusions in China: focusing on management platform and cultural problems
verfasst von:
Shuangshuang Zeng, Dong Wang, Wanli Liu, Yuanliang Yan, Minwen Zhu, Zhicheng Gong, Shusen Sun
Erschienen in:
International Journal of Clinical Pharmacy
|
Ausgabe 5/2019
Einloggen, um Zugang zu erhalten
Abstract
This article reviews the current status of the overuse of intravenous (IV) infusions in China and implications to patient safety, and analyzes factors associated with the overuse. Although many factors contribute to the overuse of IV infusions in China, we focus on the construction of an IV infusion management system and tackling cultural problems as the first step to address issues of IV therapy in this commentary.